Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-03

Clinical Trial Update: PIPAC for Peritoneal Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for PIPAC (pressurized intraperitoneal aerosol chemotherapy) in patients with peritoneal metastases, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Peritoneal Metastases | Phase 1 | Status: RECRUITING